Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C

Genome Research

Volumn 24, Issue 11, 2014, Pages 1854-1868

  Dryden, Nicola H ^a   Broome, Laura R ^a   Dudbridge, Frank ^b   Johnson, Nichola ^a   Orr, Nick ^a   Schoenfelder, Stefan ^c   Nagano, Takashi ^c   Andrews, Simon ^c   Wingett, Steven ^c   Kozarewa, Iwanka ^a   Assiotis, Ioannis ^a   Fenwick, Kerry ^a   Maguire, Sarah L ^a   Campbell, James ^a   Natrajan, Rachael ^a   Lambros, Maryou ^a   Perrakis, Eleni ^a   Ashworth, Alan ^a   Fraser, Peter ^c   Fletcher, Olivia ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; KRUPPEL LIKE FACTOR 4; LONG UNTRANSLATED RNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SOMATOMEDIN BINDING PROTEIN 5; TRANSCRIPTION FACTOR SOX2; FOXA1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOXB13 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN CELL; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; BREAST TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 2; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME MAP; DNA MICROARRAY; DNA SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PROCEDURES; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HOMEODOMAIN PROTEINS; HUMANS; MCF-7 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, DNA;

EID: 84923823453     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.175034.114     Document Type: Article

References (77)

1. The 1000 Genomes Project Consortium. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491: 56-65.
2. Affer M, Chesi M, Chen WD, Keats JJ, Demchenko YN, Roschke AV, Van Wier S, Fonseca R, Bergsagel PL, Kuehl WM. 2014. Promiscuous rearrangementsofthe MYC locus hijack enhancers and super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia 28: 1725-1735.
3. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, et al. 2010. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci 107: 9742-9746.
4. Anderson CA, Soranzo N, Zeggini E, Barrett JC. 2011. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 9: e1000580.
5. Bahcall O. 2013. Functional annotation of susceptibility loci identified by COGS. Nat Genet doi: 10.1038/ngicogs.3.
6. Belton JM, McCord RP, Gibcus JH, Naumova N, Zhan Y, Dekker J. 2012. Hi-C: a comprehensive technique to capture the conformation of genomes. Methods 58: 268-276.
7. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
8. Berger MF, Badis G, Gehrke AR, Talukder S, Philippakis AA, Pena-Castillo L, Alleyne TM, Mnaimneh S, Botvinnik OB, Chan ET, et al. 2008. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 133: 1266-1276.
9. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. 2006. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
10. Bodmer D, Schepens M, Eleveld MJ, Schoenmakers EF, Geurts van Kessel A. 2003. Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q21). Genes Chromosomes Cancer 38: 107-116.
11. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, et al. 2013. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45: 371-384.
12. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, et al. 2012. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22: 1790-1797.
13. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, et al. 2011. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20: 3289-3303.
14. Butt AJ, Dickson KA, McDougall F, Baxter RC. 2003. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278: 29676-29685.
15. The Cancer Genome Atlas Network. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
16. Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J, Moore JH, Lupien M. 2012. Breast cancer risk-associated SNPs modulate the affinity ofchromatin for FOXA1 and alter gene expression.Nat Genet 44: 1191-1198.
17. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, et al. 2010. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 42: 132-136.
18. Dekker J, Rippe K, Dekker M, Kleckner N. 2002. Capturing chromosome conformation. Science 295: 1306-1311.
19. Dekker J, Marti-Renom MA, Mirny LA. 2013. Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat Rev Genet 14: 390-403.
20. +11a phosphorylation in breast cancer cell lines. Cancer Res 67: 2657-2665.
21. Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, Perracchio L, Carstens RP, Santoni A, Bissell MJ, Nistico P. 2012. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proc Natl Acad Sci 109: 19280-19285.
22. Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA, Rubio ED, Krumm A, Lamb J, Nusbaum C, et al. 2006. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res 16: 1299-1309.
23. Dudbridge F, Fletcher O, Walker K, Johnson N, Orr N, Dos Santos Silva I, Peto J. 2012. Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases. Cancer Epidemiol Biomarkers Prev 21: 262-272.
24. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, et al. 2007. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
25. Enciso-Mora V, Hosking FJ, Kinnersley B, Wang Y, Shete S, Zelenika D, Broderick P, Idbaih A, Delattre JY, Hoang-Xuan K, et al. 2013. Deciphering the 8q24.21 association for glioma. Hum Mol Genet 22: 2293-2302.
26. The ENCODE Project Consortium. 2011. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9: e1001046.
27. The ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
28. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, et al. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49.
29. Ethier SP, Mahacek ML, Gullick WJ, Frank TS, Weber BL. 1993. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 53: 627-635.
30. Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, Karn T, Broeks A, van Leeuwen FE, van't Veer LJ, Udo R, et al. 2012. The role of genetic breast cancer susceptibility variantsasprognostic factors.Hum Mol Genet 21: 3926-3939.
31. Fletcher O, Houlston RS. 2010. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10: 353-361.
32. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, Zelenika D, Gut I, Heath S, Palles C, et al. 2011. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 103: 425-435.
33. Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP. 1999. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 81: 1328-1334.
34. Fraser P, Bickmore W. 2007. Nuclear organization of the genome and the potential for gene regulation. Nature 447: 413-417.
35. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, et al. 2011. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43: 513-518.
36. Frietze S, Wang R, Yao L, Tak YG, Ye Z, Gaddis M, Witt H, Farnham PJ, Jin VX. 2012. Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Genome Biol 13: R52.
37. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. 2012. Architecture of the human regulatory network derived from ENCODE data. Nature 489: 91-100.
38. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, et al. 2008. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100: 962-966.
39. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. 2010. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
40. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci 106: 9362-9367.
41. Huang Q, Whitington T, Gao P, Lindberg JF, Yang Y, Sun J, Vaisanen MR, Szulkin R, Annala M, Yan J, et al. 2014. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. Nat Genet 46: 126-135.
42. Hughes JR, Roberts N, McGowan S, Hay D, Giannoulatou E, Lynch M, De Gobbi M, Taylor S, Gibbons R, Higgs DR. 2014. Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet 46: 205-212.
43. Huppi K, Pitt JJ, Wahlberg BM, Caplen NJ. 2012. The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front Genet 3: 69.
44. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. 2011. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43: 27-33.
45. Jin F, Li Y, Dixon JR, Selvaraj S, Ye Z, Lee AY, Yen CA, Schmitt AD, Espinoza CA, Ren B. 2013. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503: 290-294.
46. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. 2008. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
47. Lasfargues EY, Coutinho WG, Redfield ES. 1978. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. JNatl Cancer Inst 61: 967-978.
48. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML. 2013. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152: 633-641.
49. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, et al. 2009. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326: 289-293.
50. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu H, et al. 2014. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 42: D142-D147.
51. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BA. 2008. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6: e108.
52. Miele A, Gheldof N, Tabuchi TM, Dostie J, Dekker J. 2006. Mapping chromatin interactions by chromosome conformation capture. Curr Protoc Mol Biol 80: 21.14.1-21.14.13.
53. Natoli G, Andrau JC. 2012. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet 46: 1-19.
54. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, Marchio C, Vatcheva R, Rayter S, Mahler-Araujo B, Fulford LG, et al. 2009. Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 15: 2711-2722.
55. Naumova N, Smith EM, Zhan Y, Dekker J. 2012. Analysis of long-range chromatin interactions using Chromosome Conformation Capture. Methods 58: 192-203.
56. Niland CN, Merry CR, Khalil AM. 2012. Emerging roles for long non-coding RNAs in cancer and neurological disorders. Front Genet 3: 25.
57. Orr N, Cooke R, Jones M, Fletcher O, Dudbridge F, Chilcott-Burns S, Tomczyk K, Broderick P, Houlston R, Ashworth A, et al. 2011. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men. PLoS Genet 7: e1002290.
58. Orr N, Lemnrau A, Cooke R, Fletcher O, Tomczyk K, Jones M, Johnson N, Lord CJ, Mitsopoulos C, Zvelebil M, et al. 2012. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet 44: 1182-1184.
59. Ovcharenko I, Loots GG, Nobrega MA, Hardison RC, Miller W, Stubbs L. 2005. Evolution and functional classification of vertebrate gene deserts. Genome Res 15: 137-145.
60. Phillips-Cremins JE, Corces VG. 2013. Chromatin insulators: linking genome organization to cellular function. Mol Cell 50: 461-474.
61. Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, Groenewoud A, Uitterlinden AG, Look MP, Klijn JG, Sleijfer S, et al. 2012. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat 133: 843-851.
62. Sakoda LC, Jorgenson E, Witte JS. 2013. Turning of COGS moves forward findings for hormonally mediated cancers. Nat Genet 45: 345-348.
63. Sanyal A, Lajoie BR, Jain G, Dekker J. 2012. The long-range interaction landscape of gene promoters. Nature 489: 109-113.
64. Schmidt D, Wilson MD, Spyrou C, Brown GD, Hadfield J, Odom DT. 2009. ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48: 240-248.
65. Shabalin AA. 2012. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28: 1353-1358.
66. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, et al. 2009. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
67. Simonis M, Klous P, Splinter E, Moshkin Y, Willemsen R, de Wit E, van Steensel B, de Laat W. 2006. Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat Genet 38: 1348-1354.
68. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A, et al. 2007. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869.
69. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
70. van Berkum NL, Lieberman-Aiden E, Williams L, Imakaev M, Gnirke A, Mirny LA, Dekker J, Lander ES. 2010. Hi-C: a method to study the three-dimensional architecture of genomes. J Vis Exp 39: e1869.
71. Ward LD, Kellis M. 2012. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40: D930-D934.
72. Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, et al. 2012. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the breast cancer association consortium. Cancer Epidemiol Biomarkers Prev 21: 1783-1791.
73. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
74. Wray NR, Purcell SM, Visscher PM. 2011. Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol 9: e1000579.
75. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW III, et al. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
76. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. 2010. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
77. Zhao Z, Tavoosidana G, Sjolinder M, Gondor A, Mariano P, Wang S, Kanduri C, Lezcano M, Sandhu KS, Singh U, et al. 2006. Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra-and interchromosomal interactions. Nat Genet 38: 1341-1347.